These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4790604)

  • 61. The pharmacokinetics of HI-6 in beagle dogs.
    Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
    Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
    Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic analysis of cefquinome in healthy chickens.
    Xie W; Zhang X; Wang T; Du S
    Br Poult Sci; 2013; 54(1):81-6. PubMed ID: 23444857
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pharmacokinetics and clinical evaluation of BB-K8 in children (author's transl)].
    Yoshioka H; Takimoto M; Nakatsugawa T; Maeda T; Tasaka Y
    Jpn J Antibiot; 1974 Jun; 27(3):382-8. PubMed ID: 4436951
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacokinetics of cefazolin for prophylactic administration to dogs.
    Gonzalez OJ; Renberg WC; Roush JK; KuKanich B; Warner M
    Am J Vet Res; 2017 Jun; 78(6):695-701. PubMed ID: 28541147
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.
    Karney W; Holmes KK; Turck M
    Antimicrob Agents Chemother; 1973 Mar; 3(3):338-42. PubMed ID: 4275226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pharmacokinetic studies on micronomicin in dogs. Comparison of intramuscular and drip intravenous administration models].
    Inoue A; Hara T; Deguchi T
    Jpn J Antibiot; 1983 Nov; 36(11):3262-7. PubMed ID: 6674539
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of imipenem in dogs.
    Barker CW; Zhang W; Sanchez S; Budsberg SC; Boudinot FD; McCrackin Stevenson MA
    Am J Vet Res; 2003 Jun; 64(6):694-9. PubMed ID: 12828254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The influence of amikacin (BB-K8) upon the cochlea. An electron microscopical study (author's transl)].
    Nakai Y; Yamamoto K; Zushi K; Fujimoto A
    Jpn J Antibiot; 1974 Apr; 27(2):212-7. PubMed ID: 4546684
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
    Isert D; Klesel N; Limbert M; Markus A; Seibert G; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():31-7. PubMed ID: 1601754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.
    Lin Z; Li M; Gehring R; Riviere JE
    J Pharm Sci; 2015 Jan; 104(1):233-43. PubMed ID: 25407474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Latamoxef (moxalactam) kinetics in volunteers studied by a specific HPLC assay technique.
    Shepherd AM; Hardin TC; Ludden TM; Miner DJ; Coleman DL
    J Antimicrob Chemother; 1983 Oct; 12(4):377-86. PubMed ID: 6643333
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Treatment of dermatological cases with BB-K8 (author's transl)].
    Kameyama A; Maruta H; Minami K
    Jpn J Antibiot; 1975 Aug; 28(4):525-9. PubMed ID: 808656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Studies on amikacin (BB-K8) (author's transl)].
    Seiga K; Minagawa M; Furuta N; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1974 Aug; 27(4):434-7. PubMed ID: 4215903
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs.
    Zhang B; Gu X; Li X; Gu M; Zhang N; Shen X; Li Y; Ding H
    J Vet Pharmacol Ther; 2014 Aug; 37(4):367-73. PubMed ID: 24372291
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BB-K 8, a new semisynthetic aminoglycoside antibiotic.
    Kawaguchi H; Naito T; Nakagawa S; Fujisawa KI
    J Antibiot (Tokyo); 1972 Dec; 25(12):695-708. PubMed ID: 4568692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.